Novel Sequencing Technique Reveals Previously Unseen Gaps in Immune Signaling
A groundbreaking advance in single-cell technology is revolutionizing how scientists observe immune cell behavior by capturing a more comprehensive and...
Antidepressant Fails to Prevent Chemotherapy-Induced Nerve Damage, Study Finds
A groundbreaking randomized clinical trial led by the Alliance for Clinical Trials in Oncology, supported by the National Cancer Institute,...
Daratumumab Shows Promise in Early Myeloma Stages
In a groundbreaking advancement in hematological oncology, researchers have unveiled the promising results of the Phase II D-PRISM study, which...
Furmonertinib Plus Bevacizumab Boosts EGFR-TKI Resistance Outcomes
In a groundbreaking advance for patients grappling with the daunting challenge of leptomeningeal metastasis resistant to epidermal growth factor receptor...
Innovative Urine Test Poised to Transform Bladder Cancer Treatment
Bladder cancer, a malignancy originating from the urothelial lining of the bladder, remains one of the most prevalent cancers diagnosed...
New [225Ac]-Pertuzumab Drug Shows Potent HER2 Fight
In the relentless battle against HER2-positive breast cancer, a groundbreaking breakthrough is emerging from the cutting-edge intersection of radiopharmaceuticals and...
Ulrich Steidl, MD, Ph.D., Appointed Director of Montefiore Einstein Comprehensive Cancer Center
International blood cancer and stem cell research authority Dr. Ulrich Steidl has been appointed director of the Montefiore Einstein Comprehensive...
Natural Alkaloid Gramine Inhibits Triple-Negative Breast Cancer by Triggering Ferroptosis Through the CUL3–MTDH Pathway
A groundbreaking study recently published in the distinguished journal Current Molecular Pharmacology brings to light a promising new avenue for...
Lactylation Modification Fuels Lung Cancer Growth and Therapy Resistance
In a groundbreaking review published in Current Molecular Pharmacology, researchers from Shanghai Pulmonary Hospital, led by Yong Xu, have unveiled...
Adjuvant PD-1/PD-L1 Inhibitors Demonstrate Effectiveness While Raising Safety Concerns in Solid Tumors
Programmed cell death protein-1 (PD-1) and programmed death ligand-1 (PD-L1) inhibitors have emerged as transformative agents in oncology, revolutionizing the...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!